Identification of a submicroscopic deletion of SHH associated with the holoprosencephaly spectrum by array‐based CGH

To the Editor: Holoprosencephaly (HPE) results from failure of the cerebrum to form distinct left and right hemispheres and is associated with mental retardation, hypotelorism, nasal defects, single central maxillary incisor, cleft palate, congenital nasal pyriform aperture stenosis, and microcephaly. When these craniofacial findings occur in the absence of true HPE, they may be considered microforms of the HPE spectrum. HPE is etiologically heterogeneous and may be due to chromosomal abnormalities (1) ormutations in several genes (2–11), includingSonic Hedgehog (SHH). Array-based comparative genomic hybridization (aCGH) has been used to detect chromosomal alterations in association with cancers (12, 13), mental retardation (14–16), and fetal malformations (17, 18). In this study, we used aCGH to identify a deletion of SHH in a patient with the HPE spectrum and a normal karyotype. The proband was born to African-American non-consanguineous parents with a normal birth weight. At evaluation at 22 months, features characteristic of the HPE spectrum included single central maxillary incisor, absent upper midline labial frenulum, congenital nasal pyriform aperture stenosis, microcephaly (head circumference 40.7 cm), and global developmental delay. She also had bilateral ptosis and an increased partial thromboplastin time. A brain magnetic resonance imaging showed mild reduction in frontal lobe volume without frank HPE. The karyotype (46,XX, >500 band level), and the subtelomeric fluorescence in situ hybridization (FISH) study were normal. Mutation analyses of the SHH, SIX3, ZIC2, and TGIF genes were normal (GeneDx, Bethesda, MD). Informed consent was provided upon enrollment in the IRB-approved study. The aCGH and FISH analyses were performed as described (19, 20). aCGH was performed to assess for a submicroscopic rearrangement. In aCGH, the relative intensity ratio (Cy3:Cy5 ratio) of the labeled test and control samples indicates the relative copy number. For the patient, the Cy3:Cy5 ratio (when the patient sample was labeled with Cy3) for two bacterial artificial chromosome (BAC) clones, RP11-86L18 and GS1-121J16, were 0.62 and 0.68, respectively (Fig. 1a), consistent with a deletion. RP11-86L18 and GS1-121J16 map to genomic position 153.6–155.0 Mb on 7q36 (UCSCGenome Browser, http://genome.ucsc.edu, May 2004 freeze). This deletion was not present in the patient’s unaffected mother (Fig. 1b). The patient’s father was not available for study. The deleted region was refined by FISH (Table 1). RP11-86L18 showed a signal on only one of the chromosome 7 homologs, consistent with a deletion (Fig. 1c). Additional FISH analyses refined the deletion size to 3.33–4.55 Mb and confirm that the subtelomeric region is not deleted (Table 1, Figs 1d,e). These studies demonstrate that the genomic region containing the entire SHH gene was deleted. Using aCGH, we have detected a submicroscopic deletion of 7q36 that included SHH out of a panel of five patients with the HPE spectrum. Based on previous reports of SHH alterations in association with the HPE spectrum, many of the proband’s features are likely due to haploinsufficiency of SHH. Submicroscopic deletions of SHH have been reported relatively infrequently (21–23). Most patients with the HPE spectrum do not have a defined genetic cause of the condition (11, 24), and aCGH can be a useful method for assessing these patients and could be employed after using quantitative PCR to assess for alterations in known HPE genes. With aCGH, all of the known HPE loci (including those for which a specific HPE-associated gene has not been identified) can be interrogated at once, offering an advantage over FISH analysis. Because aCGH is a genome-wide analysis, Clin Genet 2006: 69: 367–369 # 2006 The Authors Printed in Singapore. All rights reserved Journal compilation# 2006 Blackwell Munksgaard

[1]  I. Gicquel,et al.  Multicolour FISH and quantitative PCR can detect submicroscopic deletions in holoprosencephaly patients with a normal karyotype , 2005, Journal of Medical Genetics.

[2]  C. Ruivenkamp,et al.  Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH) , 2005, Journal of Medical Genetics.

[3]  T. Frebourg,et al.  Detection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformations , 2005, Journal of Medical Genetics.

[4]  E. Zackai,et al.  Array based CGH and FISH fail to confirm duplication of 8p22-p23.1 in association with Kabuki syndrome , 2005, Journal of Medical Genetics.

[5]  D. Horn,et al.  Minimal clinical expression of the holoprosencephaly spectrum and of Currarino syndrome due to different cytogenetic rearrangements deleting the sonic hedgehog gene and the HLXB9 gene at 7q36.3 , 2004, American journal of medical genetics. Part A.

[6]  L. Pasquier,et al.  Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients with features of holoprosencephaly spectrum: Mutation review and genotype–phenotype correlations , 2004, Human mutation.

[7]  D. Ledbetter,et al.  Comparative genomic hybridization-array analysis enhances the detection of aneuploidies and submicroscopic imbalances in spontaneous miscarriages. , 2004, American journal of human genetics.

[8]  M Bobrow,et al.  Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features , 2004, Journal of Medical Genetics.

[9]  Shaying Zhao,et al.  1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. , 2003, Genome research.

[10]  Ton Feuth,et al.  Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. , 2003, American journal of human genetics.

[11]  E. Roeder,et al.  Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Daniel Pinkel,et al.  Genomic microarrays in human genetic disease and cancer. , 2003, Human molecular genetics.

[13]  Maximilian Muenke,et al.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly. , 2002, American journal of human genetics.

[14]  M. Tekin,et al.  Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly , 2002, Human Genetics.

[15]  A. Schier,et al.  A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects , 2002, Human Genetics.

[16]  E. Zackai,et al.  Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination , 2000, Nature Genetics.

[17]  K. Jones,et al.  The mutational spectrum of the sonic hedgehog gene in holoprosencephaly: SHH mutations cause a significant proportion of autosomal dominant holoprosencephaly. , 1999, Human Molecular Genetics.

[18]  M. Muenke,et al.  The molecular genetics of holoprosencephaly: a model of brain development for the next century , 1999, Child's Nervous System.

[19]  A. Munnich,et al.  Expression of the Sonic hedgehog (SHH ) gene during early human development and phenotypic expression of new mutations causing holoprosencephaly. , 1999, Human molecular genetics.

[20]  E. Zackai,et al.  Mutations in the homeodomain of the human SIX3 gene cause holoprosencephaly , 1999, Nature Genetics.

[21]  D. Warburton,et al.  Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired , 1998, Nature Genetics.

[22]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[23]  S. Scherer,et al.  Mutations in the human Sonic Hedgehog gene cause holoprosencephaly , 1996, Nature Genetics.

[24]  J. Fryns,et al.  Holoprosencephaly: the Maastricht experience. , 2001, Genetic counseling.